Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-b4m5d Total loading time: 0 Render date: 2025-03-01T07:07:30.897Z Has data issue: false hasContentIssue false

Chapter 42 - Tumors of the Liver in Children

from Section V - Other Considerations and Issues in Pediatric Hepatology

Published online by Cambridge University Press:  19 January 2021

By
Milton Finegold ,
Nedim Hadžić  and
Soo-Jin Cho
Edited by
Frederick J. Suchy ,
Ronald J. Sokol  and
William F. Balistreri
Edited in association with
Jorge A. Bezerra ,
Cara L. Mack  and
Benjamin L. Shneider
Frederick J. Suchy
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
Ronald J. Sokol
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
William F. Balistreri
Affiliation:
Cincinnati Children’s Hospital Medical Center, Cincinnati
Jorge A. Bezerra
Affiliation:
Cincinnati Children’s Hospital Medical Center, Cincinnati
Cara L. Mack
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
Benjamin L. Shneider
Affiliation:
Texas Children’s Hospital, Houston
Get access

Summary

The rarity and diversity of liver tumors in children means that no center has adequate experience to deliver optimal care to every patient. Hence cooperative study groups have been essential in establishing diagnostic criteria, identifying prognostic factors, assembling new biologically important molecular data, and introducing and evaluating chemotherapy and other treatments.

Type
Chapter
Information
Liver Disease in Children , pp. 769 - 800
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Lopez-Terrada, D, Finegold, M. (2014). Tumors of the liver. In: Suchy, F, Sokol, RJ, Balistreri, WF, (Eds.), Liver Disease in Children, 4th edn. (pp. 728–59). Cambridge: Cambridge University Press.Google Scholar
Czauderna, P, Haeberle, B, Hiyama, E, et al. The Children’s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer 2016;52:92–101.Google Scholar
National Institutes of Health. Surveillance, Epidemiology, and End Results Program (SEER). Available at: https://seer.cancer.gov/csr/1975_2016/ [last accessed June 30, 2020].Google Scholar
Darbari, A, Sabin, KM, Shapiro, CN, Schwarz, KB. Epidemiology of primary hepatic malignancies in US children. Hepatology 2003;38:560–6.CrossRefGoogle Scholar
Hubbard, AK, Spector, LG, Fortuna, G, Marcotte, EL, Poynter, JN. Trends in international incidence of pediatric cancers in children under 5 years of age: 1988–2012. JNCI Cancer Spectr 2019;3:pkz007.Google Scholar
Katzenstein, HM, Krailo, MD, Malogolowkin, MH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003;97:2006–12.Google Scholar
McLaughlin, CC, Baptiste, MS, Schymura, MJ, Nasca, PC, Zdeb, MS. Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol 2006;163:818–28.Google Scholar
Spector, LG, Puumala, SE, Carozza, SE, et al. Cancer risk among children with very low birth weights. Pediatrics 2009;124:96–104.Google Scholar
Janitz, AE, Ramachandran, G, Tomlinson, GE, et al. Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children’s Oncology Group. J Expo Sci Environ Epidemiol 2017;27:359–64.CrossRefGoogle ScholarPubMed
Duffy, KA, Cohen, JL, Elci, OU, Kalish, JM. Development of the serum alpha-fetoprotein reference range in patients with Beckwith-Wiedemann spectrum. J Pediatr 2019. doi: 10.1016/j.jpeds.2019.1005.1051CrossRefGoogle Scholar
Li, M, Shuman, C, Fei, YL, et al. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Am J Med Genet 2001;102:161–8.Google Scholar
Aretz, S, Koch, A, Uhlhaas, S, et al. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 2006;47:811–18.Google Scholar
Roy, A, Finegold, MJ. Hepatic neoplasia and metabolic diseases in children. Clin Liver Dis 2010;14:731–46.Google Scholar
Evason, K, Bove, KE, Finegold, MJ, et al. Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies. Am J Surg Pathol 2011;35:687–96.Google Scholar
Scheimann, AO, Strautnieks, SS, Knisely, AS, et al. Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma. J Pediatr 2007;150:556–9.CrossRefGoogle ScholarPubMed
Vilarinho, S, Erson-Omay, EZ, Harmanci, AS, et al. Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations. J Hepatol 2014;61:1178–83.Google Scholar
Zen, Y, Vara, R, Portmann, B, Hadzic, N. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM. Histopathology 2014;64:671–82.Google Scholar
Newsome, JR, Venkatramani, R, Heczey, A, et al. Cholangiocarcinoma among children and adolescents: a review of the literature and surveillance, epidemiology, and end results program database analysis. J Pediatr Gastroenterol Nutr 2018;66:e12–e18.Google Scholar
Hadzic, N, Finegold, MJ. Liver neoplasia in children. Clin Liver Dis 2011;15:443–62,vii–x.Google Scholar
Richter, A, Grabhorn, E, Schulz, A, et al. Hepatoblastoma in a child with progressive familial intrahepatic cholestasis. Pediatr Transplant 2005;9:805–8.Google Scholar
Kadakia, N, Lobritto, SJ, Ovchinsky, N, et al. A challenging case of hepatoblastoma concomitant with autosomal recessive polycystic kidney disease and Caroli syndrome-review of the literature. Front Pediatr 2017;5:114.Google Scholar
Johansen, L, Haller, W, Thyagarajan, M, Kelly, D, McKiernan, P. Hepatic lesions associated with McCune Albright syndrome. J Pediatr Gastroenterol Nutr 2019;68:e54–e57.Google Scholar
Osada, A, Araki, E, Yamashita, Y, Ishii, T. Combination therapy of propranolol, levothyroxine, and liothyronine was effective in a case of severe consumptive hypothyroidism associated with infantile hepatic hemangioma. Clin Pediatr Endocrinol 2019;28:9–14.Google Scholar
Lemoine, C, Nilsen, A, Brandt, K, et al. Liver histopathology in patients with hepatic masses and the Abernethy malformation. J Pediatr Surg 2019;54:266–71.Google Scholar
McCarville, MB, Kao, SC. Imaging recommendations for malignant liver neoplasms in children. Pediatr Blood Cancer 2006;46:2–7.Google Scholar
Liu, AP, Wong, KN, See, QW, Chan, GC, Chiang, AK. 11 C-Acetate positron emission tomography for detection of occult metastatic recurrence in hepatoblastoma. J Pediatr Hematol Oncol 2016;38:317–20.CrossRefGoogle Scholar
Shi, Y, Commander, SJ, Masand, PM, et al. Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg 2017;52:956–61.Google Scholar
Boman, F, Bossard, C, Fabre, M, et al. Mesenchymal hamartomas of the liver may be associated with increased serum alpha foetoprotein concentrations and mimic hepatoblastomas. Eur J Pediatr Surg 2004;14:63–6.Google ScholarPubMed
Meyers, RL, Maibach, R, Hiyama, E, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration. Lancet Oncol 2017;18:122–31.CrossRefGoogle ScholarPubMed
Rudzinski, E, Ranganathan, S, Hicks, MJ, Kim, GE. Protocol for the examination of resection specimens from patients with hepatoblastoma. Available at: https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates [last accessed June 30, 2020].Google Scholar
Aronson, DC, Schnater, JM, Staalman, CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005;23:1245–52.CrossRefGoogle Scholar
Meyers, R, Trobaugh-Lotrario, AD, Malogolowkin, MH, Katzenstein, HM, Lopez-Terrada, DH, Finegold, MJ. (2016). Pediatric liver tumors. In: PA Pizzo, (Ed.), Principles and Practice of Pediatric Oncology, 7th edn. (p. 726–52). Philadelphia: Wolters Kluwer.Google Scholar
Wang, LL, Filippi, RZ, Zurakowski, D, et al. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 2010;34:287–99.CrossRefGoogle ScholarPubMed
Biegel, JA, Tan, L, Zhang, F, et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461–7.Google ScholarPubMed
Trobaugh-Lotrario, AD, Finegold, MJ, Feusner, JH. Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy. Pediatr Blood Cancer 2011;57:423–8.Google Scholar
Trobaugh-Lotrario, AD, Tomlinson, GE, Finegold, MJ, Gore, L, Feusner, JH. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 2009;52:328–34.Google Scholar
Kiss, A, Szepesi, A, Lotz, G, et al. Expression of transforming growth factor-alpha in hepatoblastoma. Cancer 1998;83:690–7.3.0.CO;2-O>CrossRefGoogle Scholar
Lopez-Terrada, D, Alaggio, R, de Davila, MT, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 2014;27:472–91.CrossRefGoogle ScholarPubMed
Zhou, S, Gomulia, E, Mascarenhas, L, Wang, L. Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable? Hum Pathol 2015;46:620–4.Google Scholar
Prokurat, A, Kluge, P, Kosciesza, A, et al. Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 2002;39:510–18.Google Scholar
Benedict, M, Zhang, X. Calcifying nested stromal-epithelial tumor of the liver: an update and literature review. Arch Pathol Lab Med 2019;143:264–8.Google Scholar
Assmann, G, Kappler, R, Zeindl-Eberhart, E, et al. beta-Catenin mutations in 2 nested stromal epithelial tumors of the liver–a neoplasia with defective mesenchymal-epithelial transition. Hum Pathol 2012;43:1815–27.Google Scholar
Mo, JQ, Dimashkieh, HH, Bove, KE. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004;35:200–9.Google Scholar
Iacobas, I, Phung, TL, Adams, DM, et al. Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr 2018;203:294–300, e292.Google Scholar
Adler, B, Naheedy, J, Yeager, N, Nicol, K, Klamar, J. Multifocal epithelioid hemangioendothelioma in a 16-year-old boy. Pediatr Radiol 2005;35:1014–18.Google Scholar
Antonescu, CR, Le Loarer, F, Mosquera, JM, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 2013;52:775–84.Google Scholar
Doyle, LA, Fletcher, CD, Hornick, JL. Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics. Am J Surg Pathol 2016;40:94–102.Google Scholar
Grassia, KL, Peterman, CM, Iacobas, I, et al. Clinical case series of pediatric hepatic angiosarcoma. Pediatr Blood Cancer 2017;64:e26627.Google Scholar
Shehata, BM, Gupta, NA, Katzenstein, HM, et al. Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol 2011;14:111–16.Google Scholar
Keller, RB, Demellawy, DE, Quaglia, A, Finegold, M, Kapur, RP. Methylation status of the chromosome arm 19q MicroRNA cluster in sporadic and androgenetic-biparental mosaicism-associated hepatic mesenchymal hamartoma. Pediatr Dev Pathol 2015;18:218–27.CrossRefGoogle ScholarPubMed
Yan, Z, Grenert, JP, Joseph, NM, et al. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis. Histopathology 2018;73:101–8.Google Scholar
Malogolowkin, MH, Stanley, P, Steele, DA, Ortega, JA. Feasibility and toxicity of chemoembolization for children with liver tumors. J Clin Oncol 2000;18:1279–84.CrossRefGoogle Scholar
Nault, JC, Couchy, G, Balabaud, C, et al. Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 2017;152:880–94, e886.Google Scholar
Sumazin, P, Chen, Y, Trevino, LR, et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 2017;65:104–21.Google Scholar
Sweet-Cordero, EA, Biegel, JA. The genomic landscape of pediatric cancers: implications for diagnosis and treatment. Science 2019;363:1170–5.Google Scholar
Cairo, S, Armengol, C, De Reynies, A, et al. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 2008;14:471–84.Google Scholar
Cairo, S, Wang, Y, de Reynies, A, et al. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A 2010;107:20471–6.Google Scholar
Hooks, KB, Audoux, J, Fazli, H, et al. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma. Hepatology 2018;68:89–102.Google Scholar
Nagata, T, Takahashi, Y, Ishii, Y, et al. Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array. Cancer Genet Cytogenet 2003;145:152–60.CrossRefGoogle ScholarPubMed
Luo, JH, Ren, B, Keryanov, S, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006;44:1012–24.Google Scholar
Litten, JB, Chen, TT, Schultz, R, et al. Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study. Pediatr Dev Pathol 2011;14:378–83.Google Scholar
Gray, SG, Eriksson, T, Ekstrom, C, et al. Altered expression of members of the IGF-axis in hepatoblastomas. Br J Cancer 2000;82:1561–7.Google Scholar
Prawitt, D, Enklaar, T, Gartner-Rupprecht, B, et al. Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms’ tumor. Nat Genet 2005;37:785–6; author reply 786–7.CrossRefGoogle Scholar
Adesina, AM, Lopez-Terrada, D, Wong, KK, et al. Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum Pathol 2009;40:843–53.Google Scholar
Hartmann, W, Kuchler, J, Koch, A, et al. Activation of phosphatidylinositol-3′-kinase/AKT signaling is essential in hepatoblastoma survival. Clin Cancer Res 2009;15:4538–45.Google Scholar
Grotegut, S, Kappler, R, Tarimoradi, S, et al. Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation. Int J Oncol 2010;36:1261–7.Google Scholar
Lee, SH, Shin, MS, Lee, JY, et al. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas. J Pathol 1999;188:207–12.Google Scholar
Eichenmuller, M, Trippel, F, Kreuder, M, et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 2014;61:1312–20.Google Scholar
Zhou, S, Venkatramani, R, Gupta, S, et al. Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution. Histopathology 2017;71:813–22.Google Scholar
Hiyama, E, Yamaoka, H, Matsunaga, T, et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer 2004;91:972–9.Google Scholar
Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 2017;169:1327–41, e1323.Google Scholar
Haines, K, Sarabia, SF, Alvarez, KR, et al. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. Pediatr Blood Cancer 2019;66:e27745.CrossRefGoogle ScholarPubMed
Graham, RP, Jin, L, Knutson, DL, et al. DNAJB1-PRKACA is specific for fibrolamellar carcinoma. Mod Pathol 2015;28:822–9.Google Scholar
Graham, RP, Lackner, C, Terracciano, L, et al. Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion. Hepatology 2018;68:1441–7.Google Scholar
Patel, NR, Salim, AA, Sayeed, H, et al. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants. Histopathology 2015;67:699–708.Google Scholar
Nguyen, R, McCarville, MB, Sykes, A, et al. Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy. Int J Clin Oncol 2018;23:900–7.Google Scholar
Malogolowkin, MH, Katzenstein, HM, Meyers, RL, et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children’s Oncology Group. J Clin Oncol 2011;29:3301–6.Google Scholar
Aronson, DC, Weeda, VB, Maibach, R, et al. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. Eur J Cancer 2019;106:126–32.Google Scholar
Lopez-Terrada, D, Gunaratne, PH, Adesina, AM, et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 2009;40:783–94.CrossRefGoogle ScholarPubMed
Li, YC, Deng, YH, Guo, ZH, et al. Prognostic value of hedgehog signal component expressions in hepatoblastoma patients. Eur J Med Res 2010;15:468–74.Google Scholar
Cristobal, I, Sanz-Alvarez, M, Luque, M, et al. The role of microRNAs in hepatoblastoma tumors. Cancers 2019;11(3):409.Google Scholar
Katzenstein, HM, Langham, MR, Malogolowkin, MH, et al. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children’s Oncology Group, multicentre, phase 3 trial. Lancet Oncol 2019;20:719–27.Google Scholar
Shi, Y, Rojas, Y, Zhang, W, et al. Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: a report from the National Cancer Database. Pediatr Blood Cancer 2017;64, e26272.Google Scholar
Katzenstein, HM, Furman, WL, Malogolowkin, MH, et al. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: a report from the Children’s Oncology Group AHEP0731 study committee. Cancer 2017;123:2360–7.Google Scholar
Liu, Y, Yue, H, Xu, S, et al. First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study. Int J Clin Oncol 2015;20:952–9.CrossRefGoogle ScholarPubMed
O’Neill, AF, Towbin, AJ, Krailo, MD, et al. Characterization of pulmonary metastases in Children with hepatoblastoma treated on Children’s Oncology Group Protocol AHEP0731 (The Treatment of Children with All Stages of Hepatoblastoma): a report from the Children’s Oncology Group. J Clin Oncol 2017;35:3465–73.Google Scholar
Cruz, RJ Jr., Ranganathan, S, Mazariegos, G, et al. Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities. Surgery 2013;153:150–9.Google Scholar
Ramos-Gonzalez, G, LaQuaglia, M, O’Neill, AF, et al. Long-term outcomes of liver transplantation for hepatoblastoma: a single-center 14-year experience. Pediatr Transplant 2018:e13250. doi: 10.1111/petr.13250Google Scholar
Tan, X, Zhang, J, Wen, Z, et al. Preoperative transcatheter arterial chemoembolization of hepatoblastoma in infants. J Vasc Interv Radiol 2014;25:1029–35.Google Scholar
Jiang, Y, Zhou, S, Shen, G, Jiang, H, Zhang, J. Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children. Medicine 2018;97:e12607.Google Scholar
Trobaugh-Lotrario, AD, Lopez-Terrada, D, Li, P, Feusner, JH. Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer 2018;65:e27103.Google Scholar
Cho, JH, Lee, YM, Starost, MF, Mansfield, BC, Chou, JY. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage. J Inherit Metab Dis 2019;42:459–69.Google Scholar
Xue, F, Shi, S, Zhang, Z, et al. Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation. Oncol Lett 2018;15:5481–8.Google Scholar
Campo, DS, Nayak, V, Srinivasamoorthy, G, Khudyakov, Y. Entropy of mitochondrial DNA circulating in blood is associated with hepatocellular carcinoma. BMC Med Genomics 2019;12:74.Google Scholar
D’Avola, D, Villacorta-Martin, C, Martins-Filho, SN, et al. High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma. Sci Rep 2018;8:11570.Google Scholar
Zhu, J, Warner, E, Parikh, ND, Lubman, DM. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches. Mass Spectrom Rev 2019;38:265–90.Google Scholar
Molina, L, Bell, D, Tao, J, et al. Hepatocyte-derived lipocalin 2 is a potential serum biomarker reflecting tumor burden in hepatoblastoma. Am J Pathol 2018;188:1895–909.Google Scholar
Bei, R, Mizejewski, GJ. Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine. Curr Mol Med 2011;11:564–81.Google Scholar
Ortiz, MV, Roberts, SS, Glade Bender, J, Shukla, N, Wexler, LH. Immunotherapeutic targeting of GPC3 in pediatric solid embryoneal tumors. Front Oncol 2019;9:108.Google Scholar
Dong, B, Lee, JS, Park, YY, et al. Activating CAR and beta-catenin induces uncontrolled liver growth and tumorigenesis. Nat Commun 2015;6:5944.Google Scholar
National Institutes of Health. ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ [last accessed June 30, 2020].Google Scholar
Vij, M, Shanmugam, NP, Reddy, MS, Sankaranarayanan, S, Rela, M. Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency. Virchows Arch 2017;471:679–83.Google Scholar
Zhou, S, Hertel, PM, Finegold, MJ, et al. Hepatocellular carcinoma associated with tight-junction protein 2 deficiency. Hepatology 2015;62:1914–16.Google Scholar
Erez, A, Shchelochkov, OA, Plon, SE, Scaglia, F, Lee, B. Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism. Am J Hum Genet 2011;88:402–21.CrossRefGoogle ScholarPubMed
Wirojanan, J, Kraff, J, Hawkins, DS, et al. Two boys with fragile x syndrome and hepatic tumors. J Pediatr Hematol Oncol 2008;30:239–41.Google Scholar
Castro Narro, GE, Gamboa Dominguez, A, Consuelo Sanchez, A, et al. Combined hepatocellular-cholangiocarcinoma in a patient with cirrhosis due to cholesteryl ester storage disease. Hepatology 2019;69:1838–41.Google Scholar
Trobaugh-Lotrario, A, Martin, J, Lopez-Terrada, D. Hepatoblastoma in a male with MECP2 duplication syndrome. Am J Med Genet A 2016;170:790–1.Google Scholar
Wu, JT, Book, L, Sudar, K. Serum alpha fetoprotein (AFP) levels in normal infants. Pediatr Res 1981;15:50–2.Google Scholar
Towbin, AJ, Meyers, RL, Woodley, H, et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 2018;48:536–54.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×